304 filings
Page 9 of 16
6-K
7d5n zm43
9 Aug 16
GW Pharmaceuticals plc Reports Third Quarter 2016 Financial Results and Operational Progress
12:00am
6-K
xr5wm1qusvsa3jt
18 Jul 16
Current report (foreign)
12:00am
6-K
l8ouf1mzarc771num
14 Jul 16
Current report (foreign)
12:00am
424B5
muurd2ha393566vp
14 Jul 16
Prospectus supplement for primary offering
12:00am
FWP
81sxaj1
13 Jul 16
Free writing prospectus
12:00am
424B5
cvm9t6
12 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
w7m 982fcc6
12 Jul 16
Current report (foreign)
12:00am
6-K
kivxhtekves8
27 Jun 16
GW Pharmaceuticals Announces Positive Phase 3 Pivotal Trial Results for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
12:00am
6-K
vn1hg utvw0zz59k7
21 Jun 16
Current report (foreign)
12:00am
CT ORDER
rb0b4hqya6vnj7m5 qfe
16 Jun 16
Confidential treatment order
12:00am
6-K
qbgq685fo86ojdhe1af
13 May 16
Current report (foreign)
12:00am
6-K
3bnp9rd
5 May 16
GW Pharmaceuticals plc Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress
12:00am
6-K
0mx7ohv
25 Apr 16
GW Pharmaceuticals Receives Orphan Drug Designation from FDA for Cannabidiol for the Treatment of Tuberous Sclerosis Complex
12:00am
6-K
11mdapgatqpmt
11 Apr 16
Current report (foreign)
12:00am
6-K
ntqnu8k55i6u 98wx2
1 Apr 16
Current report (foreign)
12:00am
6-K
lpkgogt1789uw
14 Mar 16
Current report (foreign)
12:00am
6-K
ofkvh9xyhlmpbklq
19 Feb 16
Current report (foreign)
12:00am
SC 13G/A
l5i xbuqdx
16 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
q7duxq8zw2ckevm8z
16 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
zch1sss sj4cdlf1
12 Feb 16
GW Pharmaceuticals PLC
12:00am